Department of Cardiology, Utrecht University Medical Center, Heidelberglaan 100, Utrecht, The Netherlands.
Int J Cardiovasc Imaging. 2009 Dec;25(8):847-54. doi: 10.1007/s10554-009-9485-7. Epub 2009 Aug 1.
Present guidelines discourage the use of CT coronary angiography (CTCA) in symptomatic angina patients. We examined the relation between coronary calcium score (CS) and the performance of CTCA in patients with stable and unstable angina in order to understand under which conditions CTCA might be a gate-keeper to conventional coronary angiography (CCA) in such patients. We included 360 patients between 50 and 70 years old with stable and unstable angina who were clinically referred for CCA irrespective of CS. Patients received CS and CCTA on 64-slice scanners in a multicenter cross-sectional trial. The institutional review board approved the study. Diagnostic performance of CTCA to detect or rule out significant coronary artery disease was calculated on a per patient level in pre-defined CS categories. The prevalence of significant coronary artery disease strongly increased with CS. Negative CTCA were associated with a negative likelihood ratio of <0.1 independent of CS. Positive CTCA was associated with a high positive likelihood ratio of 9.4 if CS was <10. However, for higher CS the positive likelihood ratio never exceeded 3.0 and for CS >400 it decreased to 1.3. In the 62 (17%) patients with CS <10, CTCA reliably identified the 42 (68%) of these patients without significant CAD, at no false negative CTCA scans. In symptomatic angina patients, a negative CTCA reliably excludes significant CAD but the additional value of CTCA decreases sharply with CS >10 and especially with CS >400. In patients with CS <10, CTCA provides excellent diagnostic performance.
目前的指南不鼓励在有症状的心绞痛患者中使用 CT 冠状动脉造影(CTCA)。我们研究了在稳定性和不稳定性心绞痛患者中,冠状动脉钙评分(CS)与 CTCA 表现之间的关系,以便了解在哪些情况下 CTCA 可能成为此类患者常规冠状动脉造影(CCA)的“守门员”。我们纳入了 360 名年龄在 50 至 70 岁之间的稳定性和不稳定性心绞痛患者,这些患者因临床原因被推荐进行 CCA,而不受 CS 影响。患者在多中心横断面试验中接受了 64 排扫描仪的 CS 和 CCTA。机构审查委员会批准了该研究。在预先定义的 CS 类别中,按患者水平计算了 CTCA 检测或排除显著冠状动脉疾病的诊断性能。随着 CS 的增加,显著冠状动脉疾病的患病率显著增加。独立于 CS,阴性 CTCA 的负似然比<0.1。如果 CS<10,阳性 CTCA 与 9.4 的高阳性似然比相关,但对于更高的 CS,阳性似然比从未超过 3.0,对于 CS>400,它降低到 1.3。在 CS<10 的 62 名(17%)患者中,CTCA 可靠地识别了这些患者中没有显著 CAD 的 42 名(68%),没有假阴性 CTCA 扫描。在有症状的心绞痛患者中,阴性 CTCA 可靠地排除了显著 CAD,但 CTCA 的附加价值随着 CS>10 急剧下降,尤其是随着 CS>400 而下降。在 CS<10 的患者中,CTCA 提供了出色的诊断性能。